“Comparative pharmacoeconomic assessment of apixaban vs. standard of care for the prevention of stroke in Italian atrial fibrillation patients”, FE, vol. 15, no. 1S, pp. 15–26, Dec. 2014, doi: 10.7175/fe.v15i1s.974.